Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorRhythm Diagnostic Systems

About this trial

Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.

Eligibility criteria

Qualifiers

Patient aged 65 or over

Patient eligible for remote monitoring using the MultiSense® device

No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care

Subject affiliated with a health insurance scheme

Disqualifiers

Patients already participating in an interventional clinical trial.

Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision.

Patients hospitalised without consent.

Patients unable to complete a questionnaire and without a close relative to assist them in using the solution.

Trial design

Treatments tested in this trial

  • Monitoring by MultiSense

Treatment groups

80 Participants
are divided into 1 treatment group

Locations

4
Western Cancer Institute of Angers49000, Angers France
Bergonié Insititute33000, Bordeaux France
Inter-municipal Hospital Centre of Mont-de-marsan40000, Mont-de-Marsan France
Western Cancer Institute of Nantes44000, Nantes France

Sponsors and collaborators

Rhythm Diagnostic Systems

Lead sponsor